Article Details

Bristol Myers gets FDA approval for new type of psoriasis drug | BioPharma Dive

Retrieved on: 2022-09-11 04:17:12

Tags for this article:

Click the tags to see associated articles and topics

Bristol Myers gets FDA approval for new type of psoriasis drug | BioPharma Dive. View article details on HISWAI: https://www.biopharmadive.com/news/bristol-myers-tyk2-fda-approval-sotyktu-psoriasis/631577/

Excerpt

Sotyktu targets a protein called TYK2 and has been one of the pharmaceutical company's top pipeline candidates. Published Sept. 10, 2022.

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up